Related Experiment Video

Updated: Jul 7, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

PRNP M129V homozygosity in multiple system atrophy vs. Parkinson's disease

Cyndya Shibao1, Emily M Garland, Alfredo Gamboa

  • 1Autonomic Dysfunction Center, Vanderbilt University, Nashville, TN 37232, USA.

Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society
|February 1, 2008
PubMed

Insights

Multiple system atrophy (MSA) risk may be linked to prion protein gene (PRNP) homozygosity, particularly VV genotype, compared to Parkinson's disease. Further studies are needed to confirm this association in MSA pathogenesis.

Area of Science:

  • Neurodegenerative diseases
  • Prion protein genetics
  • Neurology

Background:

  • Multiple system atrophy (MSA) is a complex neurodegenerative disorder with unknown causes.
  • It presents with a combination of autonomic, pyramidal, cerebellar, and extrapyramidal dysfunctions.
  • The genetic factors influencing MSA susceptibility are not fully understood.

Purpose of the Study:

  • To investigate the association between prion protein gene (PRNP) codon 129 polymorphism and Multiple System Atrophy (MSA).
  • To compare PRNP genotype frequencies in MSA patients versus Parkinson's disease patients and healthy controls.
  • To explore the potential role of PRNP homozygosity in MSA pathogenesis.

Main Methods:

  • A case-control study was conducted involving 63 MSA patients, 54 Parkinson's disease patients, and 126 healthy volunteers.
  • Genotyping for the M129V polymorphism in the prion protein gene (PRNP) was performed for all participants.
  • Statistical analysis compared genotype distributions across the groups.

Main Results:

  • No significant difference in codon 129 genotype distribution was found between MSA patients and healthy controls.
  • However, the frequencies of both MM and VV genotypes at PRNP codon 129 were higher in MSA patients compared to Parkinson's disease patients.
  • This suggests a potential association between PRNP homozygosity and MSA, distinct from alpha-synucleinopathies.

Conclusions:

  • Homozygosity at the PRNP codon 129 locus, especially the VV genotype, may be associated with Multiple System Atrophy (MSA).
  • These findings suggest a potential role for the prion protein in MSA pathogenesis, warranting further investigation.
  • Confirmation in independent patient cohorts is necessary to validate the association between PRNP homozygosity and MSA.

More Related Videos

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...